Cancer therapy approved by FDA uses body’s own cells as a ‘living drug’::undefined

  • Bluefruit@lemmy.worldEnglish
    31·
    4 months ago

    Iovance Biotherapeutics has priced the therapy, branded Amtagvi, at $515,000 per patient.

    Well thank goodness these kind souls made it so affordable. And im sure it will come down in price after its really proven to be effective right?

    I’m sure the RnD for this was expensive af but ffs man, even with insurance thats probably going to be out of reach for so many people.